The absence of PCSK9 resulted in the downregulation of this pathway, underscoring its significant role in modulating inflammation.105 All these findings underscore that the TLR4/NF-кB signaling pathway could be a key mechanism linking PCSK9 to the inflammatory process during the development of atherosclerosis. Here, PCSK9 is linked to atherosclerosis.